How much longer you might live without assistance on new Alzheimer’s drugs
By Sandee LaMotte, CNN (CNN) — Imagine you have just been diagnosed with mild cognitive decline due to Alzheimer’s disease. Your doctor might suggest taking one of the newer medications such as lecanemab or donanemab, which have been shown in clinical trials to clear plaque-causing amyloid proteins from the brain that are the hallmark of
Continue Reading